Generics and Pharmaceuticals

///Generics and Pharmaceuticals

Price competition for generic drugs linked to increase in manufacturing-related recalls

Researchers from three universities have found that extreme price competition in the generic pharmaceutical market -- designed to make medications more affordable -- may be putting more patients at serious health risk, as evidenced by a higher number of product recalls caused by manufacturing-related problems. The same research, published online today in the Journal of

2018-06-09T08:07:00+00:00 Tags: |

Most popular vitamin and mineral supplements provide no health benefit, study finds

The most commonly consumed vitamin and mineral supplements provide no consistent health benefit or harm, suggests a new study led by researchers at St. Michael's Hospital and the University of Toronto. Published today in the Journal of the American College of Cardiology, the systematic review of existing data and single randomized control trials published in

2018-05-30T08:33:07+00:00 Tags: |

Do generic drugs compromise on quality?

You've no doubt seen them in the grocery store — typically drab-looking packages on the bottom shelf containing lower-priced generic versions of popular brand-name products. Some shoppers look at them with skepticism: Are they really as good? Or does cheaper just mean lower quality? Many people have the same questions about generic prescription medications, says

2018-05-29T08:03:45+00:00 Tags: |

Nonprofit Manufacturer Could Keep Generic Drug Costs Down

HealthDay News — A nonprofit manufacturer could help keep generic drug prices down and maintain their supply, according to a perspective piece published in the issue of the New England Journal of Medicine. Dan Liljenquist, J.D., from Intermountain Healthcare in Salt Lake City, and colleagues discuss generic drug market failure, whereby a generic drug manufacturer

2018-05-24T04:56:59+00:00 Tags: |

How to free Indians from the medical poverty trap

India is the largest supplier of generic drugs in the world, and Indian pharmaceutical companies have famously succeeded in pushing down the cost of medication in many countries across the world. Yet, too many Indian citizens do not get access to medicines owing to high costs. The preferred solution of the government right now—price control—is

2018-05-14T07:40:17+00:00 Tags: |

How this pharma executive retired to help people around the world

I am a veteran of Big Pharma. I spent 11 years at Abbott Labs ABT, +1.12% and 16 years at Bristol-Myers BMY, +0.24%  I also spent two years as a pharmaceutical consultant. For almost three decades, I saw annual sales charts that showed the hot spots for pharmaceutical sales. Currently more than 90% of drugs are sold in developed countries and

Who’s investing in health care R&D?

A recent Brookings research report found that the private sector—including pharmaceutical companies, venture capital firms, and impact investors—devotes at least $159.9 billion to investments related to health care research and development (R&D) annually. Though many organizations and publications have measured public sector spending on drugs, vaccines, and therapeutics, the Brookings report is the first to quantify the

New affordable hepatitis C combination treatment shows 97 percent cure rate

An affordable hepatitis C combination treatment including the new drug candidate ravidasvir has been shown to be safe and effective, with extremely high cure rates for patients, including hard-to-treat cases, according to interim results from the Phase II/III STORM-C-1 trial presented by the non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) at

2018-04-24T07:01:19+00:00 Tags: |

Why We May Lose Generic Drugs

The mood at the annual generic drug industry confab in Orlando in February was especially somber. The discussion during one panel was all about plunging drug prices, consolidation among drug-buying groups, and the increasingly cutthroat nature of the business. A top executive at Israel-based Teva Pharmaceutical Industries Ltd., the No. 1 supplier of generics in the U.S.,

Antiepileptic drugs increase risk of Alzheimer’s and dementia

The use of antiepileptic drugs is associated with an increased risk of Alzheimer's disease and dementia, according to a new study from the University of Eastern Finland and the German Center for Neurodegenerative Diseases, DZNE. Continuous use of antiepileptic drugs for a period exceeding one year was associated with a 15 percent increased risk of

2018-04-10T08:03:49+00:00 Tags: |

‘Coffee filter’ helps make new cancer drug Z-endoxifen 1000 times cheaper

Making drugs cheaper doesn’t always require pricey investments. A joint initiative by researchers from TU Eindhoven, the Dutch company Syncom BV and the Antoni van Leeuwenhoek hospital proves just that. What started out as a Bachelor project at TU/e laid the foundation for a much cheaper production of the promising cancer drug Z-endoxifen. Tamoxifen is

2018-04-07T09:19:19+00:00 Tags: |

Probe Into Generic Drug Price Fixing Set To Widen

Forty-five states and the Department of Justice are claiming that generic-drug prices are fixed and the alleged collusion may have cost U.S. business and consumers more than $1 billion. In their complaint, prosecutors say that when pharmacies asked drugmakers for their lowest price, the manufacturers would rig the bidding process. "The companies would work out

2018-03-31T06:40:05+00:00 Tags: |

Generic industry boss: SPC manufacturing waiver won’t harm originators’ innovation

The generic industry’s request for an SPC (supplementary protection certificates)  manufacturing waiver, which would allow them to produce in the EU SPC-protected drugs for other markets, does not influence or harm innovators’ rights, Marc–Alexander Mahl told EURACTIV.com in an interview. He said that the originators’ arguments for rejecting such a waiver and protecting their own rights

2018-03-31T06:17:23+00:00 Tags: |

Everyone wants to kill generic drug loophole — except drug makers and some GOP leaders

It’s so unpopular that lawmakers from both parties and President Trump’s top drug regulator want to kill it. But the pharmaceutical industry, flexing its powerful lobbying muscles, is successfully fighting back efforts to end a loophole that costs taxpayers and consumers billions of dollars a year. In recent years brand-name drug makers realized they could

Probe Into Generic Drug Price Fixing Set To Widen

Forty-five states and the Department of Justice are claiming that generic-drug prices are fixed and the alleged collusion may have cost U.S. business and consumers more than $1 billion. In their complaint, prosecutors say that when pharmacies asked drugmakers for their lowest price, the manufacturers would rig the bidding process. "The companies would work out in

Patients Eagerly Awaited a Generic Drug. Then They Saw the Price.

When Teva Pharmaceuticals announced recently that it would begin selling a copycat version of Syprine — an expensive drug invented in the 1960s — the news seemed like a welcome development for people taking old drugs that have skyrocketed in price. Syprine, which treats a rare condition known as Wilson disease, gained notoriety after Valeant Pharmaceuticals

The pioneer of India’s biotech industry was denied her first job for being a woman

After failing the exam for medical school, Kiran Mazumdar-Shaw trained as a professional brewmaster. When no company in India’s male-dominated beer industry would hire her, despite her education and certification, she decided to start her own business developing industrial enzymes. Thirty years later, Mazumdar-Shaw is chairman and CEO of Biocon, India’s largest biotech company and

2018-02-15T11:13:50+00:00 Tags: |

Health system-led drug company unlikely to make a dent in drug prices, shortages

As four not-for-profit health systems unveiled plans to create their own generic drug company Thursday, experts say they'll face an uphill battle to make a significant dent in one of the fastest-growing industry expenses and persistent problems: rising drug prices and drug shortages. Intermountain Healthcare, Ascension, SSM Health and Trinity Health are working with the

2018-02-14T07:33:13+00:00 Tags: |